Overexpression of sortilin is associated with 5‐FU resistance and poor prognosis in colorectal cancer
Sabrina Blondy(Raptamer Discovery Group (United States)), Aurélie Perraud(Inserm)
Cited by 20
Related Papers
5‐Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes
|Cancer Science|2020|477
Pharmacological targeting of the protein synthesis mTOR/4E‐BP1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistance
|EMBO Molecular Medicine|2015|196
FAK activity in cancer‐associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer
|EMBO Molecular Medicine|2020|105